Preview

Medical Genetics

Advanced search
Open Access Open Access  Restricted Access Subscription Access

Wilson-Konovalov disease in pediatric practice: molecular genetic features, relationships between genotype and phenotype

https://doi.org/10.25557/2073-7998.2026.02.33-44

Abstract

Objective. To determine the spectrum and relative frequencies of pathogenic variants of the ATP7B gene and to study the relationships between the genotype and phenotype of the disease in Russian children with Wilson-Konovalov disease.
Methods. The study included 100 children (3-17 years old) with a genetically verified diagnosis of fibroid tumor, observed in the period 2012-2023, who underwent a comprehensive examination: the level of ceruloplasmin in the blood and daily excretion of copper in the urine were determined, magnetic resonance imaging of the brain, ophthalmological examination using a slit lamp, indirect fibroelastometry (the degree of fibrosis was assessed using the METAVIR scale). A search for specific variants of the ATP7B gene was performed using real-time PCR, Sanger sequencing, and high-throughput sequencing (HTS).
Results. 51 pathogenic variants of ATP7B were detected, including 14 previously unknown. The most common variants were c.3207C>A, detected on 45.5% of alleles, c.3402del – 6.5%, c.3190G>A – 6%, and c.2304insC – 5.5%. The presence of the major c.3207C>A genotype is associated with late onset and mild liver damage, while the presence of variants leading to premature translation termination are associated with early onset, severe liver damage, and lower ceruloplasmin levels (p < 0.001). The diagnostic efficacy of the standard PCR panel, assessed by the detection of two pathogenic variants, was only 39%, while the high-throughput sequencing allowed the identification of biallelic variants in 99% of patients.
Conclusion. A unique spectrum of ATP7B gene variants with pronounced genetic heterogeneity has been identified in the Russian children with WKD. The established relationships between WKD genotype and age of onset, the degree of liver damage, and ceruloplasmin levels offer potential for predicting the course of the disease and improving diagnostic algorithms.

About the Authors

A. D. Komarova
National Medical Research Center for Children’s Health, Ministry of Health of the Russian Federation
Russian Federation

 Alina D. Komarova

2-1, Lomonosovsky Prospekt, 119991, Russian Federation 



K. V. Savostyanov
National Medical Research Center for Children’s Health, Ministry of Health of the Russian Federation
Russian Federation

2-1, Lomonosovsky Prospekt, 119991, Russian Federation 



A. S. Potapov
National Medical Research Center for Children’s Health, Ministry of Health of the Russian Federation; I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)
Russian Federation

2-1, Lomonosovsky Prospekt, 119991, Russian Federation 

8, Trubetskaya st., Moscow, 119991, Russian Federation



A. A. Pushkov
National Medical Research Center for Children’s Health, Ministry of Health of the Russian Federation
Russian Federation

2-1, Lomonosovsky Prospekt, 119991, Russian Federation 



D. S. Demyanov
National Medical Research Center for Children’s Health, Ministry of Health of the Russian Federation
Russian Federation

2-1, Lomonosovsky Prospekt, 119991, Russian Federation 



A. P. Fisenko
National Medical Research Center for Children’s Health, Ministry of Health of the Russian Federation
Russian Federation

2-1, Lomonosovsky Prospekt, 119991, Russian Federation 



References

1. EASL-ERN Clinical Practice Guidelines on Wilson’s disease. J Hepatol. 2025; 22:S0168-8278(24)02706-5. DOI: 10.1016/j.jhep.2024.11.007

2. Ovchinnikova E.V., Garbuz M.M., Ovchinnikova A.A. et al. Epidemiology of Wilson’s Disease and Pathogenic Variants of the ATP7B Gene Leading to Diversified Protein Disfunctions. Int. J. Mol. Sci. 2024; 25: 2402. DOI: 10.3390/ ijms25042402

3. Clinical guidelines for “Copper metabolism disorder (Wilson’s disease)” 2024. Available at: https://static.edu.rosminzdrav.ru/fc0001/fdpo/decanat/NMO_MZ/TEOC/u14/2024/KR_BV.pdf

4. Socha P., Janczyk W., Dhawan A. et al. Wilson’s Disease in Children: A Position Paper by the Hepatology Committee of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2018;66(2):334-344. DOI: 10.1097/MPG.0000000000001787.

5. Chanpong A., Dhawan A. Wilson disease in children and young adults, State of the art. Saudi J Gastroenterol. 2022;28(1):21-31. DOI: 10.4103/sjg.sjg_501_21

6. Ferenci P., Stremmel W., Członkowska A. et al. Age, sex, but not ATP7B genotype effectively influences the clinical phenotype of Wilson disease. Hepatology. 2019 Apr;69(4):1464-1476. DOI: 10.1002/hep.30280

7. Komarova A.D., Potapov A.S., Kurbatova O.V. et al. Diagnosticheskiye shkaly bolezni Vil’sona– Konovalova u detey: ogranicheniya i puti optimizatsii [Diagnostic scales for Wilson-Konovalov disease in children: limitations and methods for optimization]. Voprosy detskoy diyetologii [Pediatric Nutrition]. 2025; 23(3): 13–23. (In Russ.) DOI: 10.20953/1727-5784-2025-3-13-23

8. The Human Gene Mutation Database of the Institute of Medical Genetics in Cardiff. Available from: http://www.hgmd.cf.ac.uk/ac/gene.php?gene=ATP7B. Accessed January 2024.

9. Li M., Ma J., Wang W. et al. Pathogenic variant analysis of the ATP7B gene and genotype-phenotype correlation in Chinese patients with Wilson disease. BMC Gastroenterol. 2021;21(1):339. DOI: 10.1186/s12876-021-01911-5.

10. Gomes A., Dedoussis G.V. Geographic distribution of ATP7B mutations in Wilson disease. Annals of Human Biology. 2015; 43(1): 1–8. DOI:10.3109/03014460.2015.1051492

11. Thomas G.R., Roberts E.A., Walshe J.M. et al. Haplotypes and mutations in Wilson disease. Am. J. Hum. Genet. 1995; 56: 1315–1319.

12. Margarit E., Bach V., Gómez D. et al. Pathogenic variant analysis of Wilson disease in the Spanish population—Identification of a prevalent substitution and eight novel pathogenic variants in the ATP7B gene. Clin. Genet. 2005; 68: 61–68.

13. Gupta A., Bhattacharjee A., Dmitriev O.Y. et al. Cellular copper levels determine the phenotype of the Arg875 variant of ATP7B/Wilson disease protein. Proc Natl Acad Sci USA. 2011; 29;108(13):5390-5. DOI 10.1073/pnas.1014959108.

14. Al Jumah M., Majumdar R., Al Rajeh S. et al. A clinical and genetic study of 56 Saudi Wilson disease patients: Identification of Saudispecific mutations. Eur. J. Neurol. 2004; 11: 121–124. DOI: 10.1046/j.1351-5101.2003.00729.x

15. Borodinov A. G., Manoilov V. V., Zarutsky I. V. et al. Pokoleniya metodov sekvenirovaniya DNK (obzor) [Generations of DNA sequencing methods (review)]. Nauchnoe priborostroenie [Scientific instrumentation]. 2020; 30(4): 3–20. (In Russ.)

16. Garbuz M., Ovchinnikova E., Ovchinnikova A. et al. Spectrum of Pathogenic Variants of the ATP7B Gene and Genotype–Phenotype Correlation in Eastern Eurasian Patient Cohorts with Wilson’s Disease. Biomedicines. 2024; 12: 2833. DOI: 10.3390/biomedicines12122833

17. Ferenci P. Phenotype-genotype correlations in patients with Wilson’s disease. Ann N Y Acad Sci. 2014;1315:1-5. doi: 10.1111/nyas.12340.

18. Gorukmez O., Özgür T., Gorukmez O. et al. ATP7B Gene Variant Profile İdentified by NGS in Wilson’s Disease. Fetal Pediatr Pathol. 2023;42(6):891-900. DOI: 10.1080/15513815.2023.2260005.

19. Sipilä J. O.T. , Kytövuori L., Kaasinen V. Clinical spectrum and genotype-phenotype associations in Finnish patients with Wilson’s disease, J Neurol Sci . 2023 15:448:120620. DOI: 10.1016/j.jns.2023.120620.

20. Tomic A., Dobricic V., Novakovic I. et al. Mutational analysis of ATP7B gene and the genotype-phenotype correlation in patients with Wilson’s disease in Serbia. Military Medical and Pharmaceutical Journal of Serbia.2013;70(5):457–462. DOI:10.2298/vsp1305457t

21. Gromadzka G., Schmidt H.H., Genschel J. et al. Frameshift and nonsense mutations in the gene for ATPase7B are associated with severe impairment of copper metabolism and with an early clinical manifestation of Wilson’s disease. Clin Genet. 2005;68(6):524-532. DOI: 10.1111/j.1399-0004.2005.00528.x

22. Couchonnal E., Bouchard S., Sandahl T.D. et al. ATP7B variant spectrum in French pediatric Wilson disease cohort. Eur J Med Genet. 2021;64(10):104305. DOI: 10.1016/j.ejmg.2021.104305.

23. Balashova MS. Otsenka spektra mutatsiy gena ATP7B i klinicheskogo polimorfizma bolezni Vil’sona-Konovalova. Avtoreferat diss. kand. med. nauk [Evaluation of the spectrum of mutations of the ATP7B gene and clinical polymorphism of Wilson-Konovalov disease. Abstract of a PhD dissertation]. M., 2017 (In Russ.).

24. Ryzhkova O.P., Kardymon O.L., Prokhorchuk E.B., et al. Rukovodstvo po interpretatsii dannykh posledovatel’nosti DNK cheloveka, poluchennykh metodami massovogo parallel’nogo sekvenirovaniya (MPS) (redaktsiya 2018, versiya 2) [Guidelines for interpretation of human DNA sequencing data obtained by massive parallel sequencing (MPS) (2018 revision, version 2)]. Meditsinskaya Genetika [Medical Genetics]. 2019;18 (2):3-23. (In Russ.) doi: 10.25557/2073-7998.2019.02.3-23

25. Komarova A.D., Potapov A.S., Savostyanov K.V. et al. Slozhnosti diagnostiki bolezni Vil’sona u detey rannego vozrasta [Challenges in the diagnosis of Wilson’s disease in young children]. Vopr. det. dietol. [Pediatric Nutrition]. 2024; 22(2): 13–21. (In Russ.). DOI: 10.20953/1727-5784-2024-2-13-21

26. Savostyanov K.V. Sovremennyye algoritmy geneticheskoy diagnostiki redkikh nasledstvennykh bolezney u rossiyskikh patsiyentov: Informatsionnyye materialy. [Advanced algorithms for genetic diagnosis of rare hereditary diseases in Russian patients: Information materials]. Moskva: OOO “Poligrafist i izdatel’ [Moscow – “Polygraphist and Publishers”], 2022. – 452. (In Russ.)

27. Balashova M. S., Tuluzanovskaya I. G., Glotov O. S., et al. The spectrum of pathogenic variants of the ATP7B gene in Wilson disease in the Russian Federation. Trace Elem Med Biol. 2020;59:126420. doi: 10.1016/j.jtemb.2019.126420.

28. Nicastro E., Loudianos G., Zancan L. et al. Genotype–phenotype correlation in Italian children with Wilson’s disease. Journal of Hepatology. 50(3), 555–561. DOI:10.1016/j.jhep.2008.09.020


Review

For citations:


Komarova A.D., Savostyanov K.V., Potapov A.S., Pushkov A.A., Demyanov D.S., Fisenko A.P. Wilson-Konovalov disease in pediatric practice: molecular genetic features, relationships between genotype and phenotype. Medical Genetics. 2026;25(2):33-44. (In Russ.) https://doi.org/10.25557/2073-7998.2026.02.33-44

Views: 102

JATS XML

ISSN 2073-7998 (Print)